AIHealthcare Analytics

Knowledge Wiki

Wiki › AI Use by Government Healthcare Agencies — Public Interest Analysis

AI Use by Government Healthcare Agencies — Public Interest Analysis

OVERVIEW
Rev 5 Aug 20, 2026 00:02 UTC 1 sources

Overview The Petrie-Flom Center at Harvard Law School examines whether AI use by government healthcare agencies — including HHS, FDA, CMS, and related bodies — serves the public interest, raising questions about transparency, accountability, democratic legitimacy, and the appropriate scope of algorithmic decision-making in public health administration. The Public Interest Question The analysis centers on whether government agencies deploying AI to make or support decisions affecting healthcare access, coverage, and regulation are doing so in ways that are transparent, accountable, and aligned with public welfare. Key concerns include: algorithmic opacity in coverage determinations, lack of public notice and comment for AI system deployments, and the risk that AI optimizes for efficiency metrics that conflict with equity goals. Transparency and Accountability Gaps Government healthcare agencies face the same transparency challenges as private actors, but with additional democratic accountability obligations. When CMS uses AI for prior authorization, or FDA uses AI to prioritize regulatory review, the public has a legitimate interest in understanding how those systems work, what data they use, and how errors are identified and corrected. Regulatory and Policy Implications The Petrie-Flom analysis suggests that existing administrative law frameworks — notice-and-comment rulemaking, Freedom of Information Act requirements, and civil rights protections — may be insufficient to…

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index